Right ventricular endomyocardial biopsy in patients with cardiac magnetic resonance showing left ventricular myocarditis

Aims The aim of this study was to evaluate the sensitivity of right ventricular endomyocardial biopsy (EMB) in myocarditis patients with cardiac magnetic resonance (CMR) and electroanatomical mapping (EAM) showing left ventricular abnormalities. Methods We performed right ventricular EMB in 144 consecutive patients (66% men, age 43 ± 15 years) with acute symptoms and CMR-proved diagnosis of left ventricular myocarditis. Right ventricular EMB sensitivity has been evaluated in patients with different localization and extension of abnormal substrate at both CMR and -- when performed -- EAM. Abnormal substrate was defined, respectively, by late gadolinium enhancement (LGE) and low-voltage areas (LVAs). Results Globally, right ventricular EMB sensitivity was 87.5%. EMB-negative cases had significantly smaller fragment sizes (cumulative area 2.8 ± 1.7 vs. 3.8 ± 1.8 mm2, P = 0.023), and lower LGE surface extension (24.7 ± 14.2 vs. 38.5 ± 20.2%, P = 0.006) and transmurality (32.0 ± 26.1 vs. 49.3 ± 22.6, P = 0.003). Right ventricular EMB sensitivity in patients with LGE involving both right ventricular and interventricular septum (IVS), isolated right ventricular or IVS, and remote left ventricular areas (n = 10, 49 and 67 cases) was 83.3, 84.4 and 90.5%, respectively (P = 0.522). Overall, 34 patients (23.6%) underwent EAM. On the basis of EAM, right ventricular EMB sensitivity was 85.3%: in detail, it was 50.0, 88.2 and 86.7% in patients with both right ventricular and IVS, isolated right ventricular/IVS and distant left ventricular involvement (n = 2, 17 and 15, respectively, P > 0.05). Sample size area was the only factor associated with right ventricular EMB sensitivity (hazard ratio = 1.6/mm2, 95% confidence interval 1.1–2.4, P = 0.013). Conclusion Right ventricular EMB is still an accurate technique to confirm diagnosis in patients with CMR-proved left ventricular myocarditis. In particular, provided there is an adequate sample size, its sensitivity is comparable among patients with heterogeneous LGE or LVA localization.

[1]  A. Frontera,et al.  The COVID-19 challenge to cardiac electrophysiologists: optimizing resources at a referral center , 2020, Journal of Interventional Cardiac Electrophysiology.

[2]  C. Campochiaro,et al.  Therapeutic strategies for virus-negative myocarditis: a comprehensive review. , 2020, European journal of internal medicine.

[3]  S. Rizzo,et al.  Ventricular Arrhythmias in Myocarditis: Characterization and Relationships With Myocardial Inflammation. , 2020, Journal of the American College of Cardiology.

[4]  P. Della Bella,et al.  [Diagnostic and therapeutic approach to myocarditis patients presenting with arrhythmias]. , 2020, Giornale italiano di cardiologia.

[5]  C. Basso,et al.  Septal Late Gadolinium Enhancement and Arrhythmic Risk in Genetic and Acquired Non-Ischaemic Cardiomyopathies. , 2019, Heart, lung & circulation.

[6]  S. Rizzo,et al.  Arrhythmias in myocarditis: State of the art. , 2019, Heart rhythm.

[7]  P. Noseworthy,et al.  The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a systematic review , 2018, Journal of Interventional Cardiac Electrophysiology.

[8]  M. Uecker,et al.  Targeted endomyocardial biopsy guided by real-time cardiovascular magnetic resonance , 2017, Journal of Cardiovascular Magnetic Resonance.

[9]  G. Schuler,et al.  Biventricular endomyocardial biopsy in patients with suspected myocarditis: Feasibility, complication rate and additional diagnostic value. , 2017, International journal of cardiology.

[10]  C. Yancy,et al.  Current Diagnostic and Treatment Strategies for Specific Dilated Cardiomyopathies: A Scientific Statement From the American Heart Association. , 2016, Circulation.

[11]  G. Gerosa,et al.  Endomyocardial biopsy under echocardiographic monitoring. , 2016, Multimedia Manual of Cardio-Thoracic Surgery.

[12]  A. Natale,et al.  Feasibility of Combined Unipolar and Bipolar Voltage Maps to Improve Sensitivity of Endomyocardial Biopsy , 2015, Circulation. Arrhythmia and electrophysiology.

[13]  G. Thiene,et al.  Diagnostic use of the endomyocardial biopsy: a consensus statement , 2013, Virchows Archiv.

[14]  Andrea Frustaci,et al.  Randomized study on the efficacy of immunosuppressive therapy in patients with virus-negative inflammatory cardiomyopathy: the TIMIC study. , 2009, European heart journal.

[15]  Matthias Gutberlet,et al.  Cardiovascular Magnetic Resonance in Myocarditis: A JACC White Paper , 2009 .

[16]  Udo Sechtem,et al.  Cardiovascular Magnetic Resonance Assessment of Human Myocarditis: A Comparison to Histology and Molecular Pathology , 2004, Circulation.